These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29962466)

  • 1. [Forefront of Cancer Targeting Therapy].
    Utoguchi N; Taira Y
    Yakugaku Zasshi; 2018; 138(7):901-902. PubMed ID: 29962466
    [No Abstract]   [Full Text] [Related]  

  • 2. Algeta and Ablynx collaborate to discover and develop targeted cancer therapies.
    King G
    Future Med Chem; 2013 Feb; 5(2):123. PubMed ID: 23476969
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
    Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
    Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An accelerated pathway for targeted cancer therapies.
    McClellan M; Benner J; Schilsky R; Epstein D; Woosley R; Friend S; Sidransky D; Geoghegan C; Kessler D
    Nat Rev Drug Discov; 2011 Feb; 10(2):79-80. PubMed ID: 21283090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pregnane X receptor: a novel target for anticancer drug development.
    Rathod V; Jain S; Nandekar P; Sangamwar AT
    Drug Discov Today; 2014 Jan; 19(1):63-70. PubMed ID: 23974067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted drug delivery to tumors: myths, reality and possibility.
    Bae YH; Park K
    J Control Release; 2011 Aug; 153(3):198-205. PubMed ID: 21663778
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances of thermally responsive nanogels for cancer therapy.
    Wang Y; Xu H; Ma L
    Ther Deliv; 2015; 6(10):1157-69. PubMed ID: 26478174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of disease-relevant genes for molecularly-targeted drug discovery.
    Kauselmann G; Dopazo A; Link W
    Curr Cancer Drug Targets; 2012 Jan; 12(1):1-13. PubMed ID: 22165964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
    Kibria G; Hatakeyama H; Harashima H
    Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle and targeted systems for cancer therapy.
    Brannon-Peppas L; Blanchette JO
    Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle therapeutics: Technologies and methods for overcoming cancer.
    Cerqueira BB; Lasham A; Shelling AN; Al-Kassas R
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):140-51. PubMed ID: 26515260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumour-supportive cellular machineries in anticancer drug development.
    Dobbelstein M; Moll U
    Nat Rev Drug Discov; 2014 Mar; 13(3):179-96. PubMed ID: 24577400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF-1/CSF-1R targeting agents in clinical development for cancer therapy.
    Ries CH; Hoves S; Cannarile MA; Rüttinger D
    Curr Opin Pharmacol; 2015 Aug; 23():45-51. PubMed ID: 26051995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scientists Journey Into Genomes Via CRISPR-Cas9.
    Ricks D
    J Natl Cancer Inst; 2015 Nov; 107(11):djv352. PubMed ID: 26538621
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumour-targeted drug and gene delivery: principles and concepts.
    Cassidy J; Schätzlein AG
    Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.